<DOC>
	<DOCNO>NCT00238914</DOCNO>
	<brief_summary>The overall goal research project test newly develop behavioral therapy enhance efficacy naltrexone maintenance make viable alternative methadone maintenance detoxification method treatment opiate dependence . HYPOTHESES : 1 . Outpatient treatment Behavioral Naltrexone Therapy yield low rate relapse illicit opiate compare naltrexone plus Compliance Enhancement ( CE ) Therapy . 2 . Lifetime history depression predict dysphoria non-compliance naltrexone .</brief_summary>
	<brief_title>Opiate Dependence : Combined Naltrexone/Behavior Therapy - 1</brief_title>
	<detailed_description>Long-term maintenance naltrexone proven efficacy treatment opiate dependence , successful clinically least three problem : 1 ) The transition opiate naltrexone precipitate opiate withdrawal unless patient opiate least seven day ; 2 ) Compliance issue : patient miss naltrexone dos begin experience effect illicit opiates become re-addicted , point naltrexone restart without precipitate withdrawal ; 3 ) Naltrexone may produce dysphoria patient . The propose research study offer opiate dependent patient brief hospitalization rapid detoxification opiate naltrexone , use buprenorphine , clonidine clonazepam . If patient already undergone detoxification outside unit , assessed opiate dependence use naloxone challenge . Patients either discharge enter directly outpatient treatment randomly assign either newly develop `` Behavioral Naltrexone Therapy '' ( BNT ) , hybrid Relapse Prevention , Community Reinforcement Approach , Network Therapy Compliance Enhancement ( CE ) therapy , control therapy intend simulate outpatient psychiatric care . BNT employ behavioral incentive enlist member family social network reinforce naltrexone compliance abstinence . In current investigation , BNT CE , patient maintain oral naltrexone . Patients stratify baseline presence absence lifetime depressive disorder , investigator hypothesize predict dysphoria naltrexone non-compliance . Patients discharge hospital , enter directly , outpatient treatment STARS NYSPI receive counsel Naltrexone , 50 mg per day .</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Heroin Dependence</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Inclusion : 1 . Adult , aged 1860 . 2 . Meets DSMIV criterion current opiate dependence disorder least six month duration , support positive urine opiate positive naloxone challenge test diagnosis unclear . 3 . Able give inform consent . 4 . At least one significant willing interview possible participation treatment . Exclusion : 1 . Pregnancy , lactation , failure sexually active woman use adequate contraceptive method . 2 . Active medical illness might make participation hazardous , untreated hypertension , unstable cardiovascular disease , acute hepatitis SGOT SGPT &gt; 23 time normal , unstable diabetes , AIDS dementia . 3 . Active psychiatric disorder might interfere participation make participation hazardous , include DSMIV schizophrenia , bipolar disorder mania psychosis , depressive disorder suicide risk 1 suicide attempt within past year . 4 . History allergic reaction naloxone , naltrexone , buprenorphine , clonidine , clonazepam . 5 . Currently prescribe regularly take opiate chronic pain medical illness . 6 . Current participation another intensive treatment program currently prescribe psychotropic medication last 30 day . 7 . Current participation Methadone Maintenance program and/or regular and/or Dependent use street methadone . 8 . Opiatedependent individual seek methadone maintenance treatment . 9 . History accidental drug overdose last three year define episode opioidinduced unconsciousness incapacitation , whether medical treatment seek receive .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>